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Seminar on "Biological !!p!pling for monitoring 
population exposure to lead" 
A seminar on "Biological dampling for monitoring population 
exposure to lead" began today under the joint sponsorship of the 
Commission of the European Communities {Health Protection Directorate), 
Luxembourg,and the Western Health Board, Regional Hospital, Galway, 
Ireland. 
It will judge the organisation of the extensive number of 
epidemiological surveys on lead which have been carried out in Europe in 
the past few years. The seminar will end on Wednesday. 
About SO participants, including representatives of the nine 
Member States of the European Communities, are attending this Seminar as 
well as observers from the World Health Organisation. 
On April 16, 1975 the Commission submitted proposals to the Council 
of Ministers aimed at protecting human health from the presence of lead 
in the environment. One deals with biological standards and with screen-
ing the population for lead exposure, and the other deals with air 
quality standards for lead. 
These proposed directives have been submitted in accordance with 
the Action Programme on the Environment adopted by the Council of 
Ministers on November 22, 1973 in which lead and its compounds are 
considered as pollutants for top priority consideration. 
The directive on biological standards provides for biological 
sampling of the population to determine the lead levels in terms of the 
biological standards for different sectors of a population group. 
The Galway Seminar, after evaluating the previous epidemiological 
surveys, will develop guidelines for biological sampling to be used in 
conj·unction with the directive. 
The application of these guidelines will be evaluated within the 
framework of a pilot project to be conducted in Ireland. The ·scheme for 
this project will be presented and discussed at the seminar. In this 
contect the experience gained by the Western Health Board, Regional 
Hospital, Galway, acting in conjunction with the Commission, during a 
study of blood lead levels and enzyme activities in Galway and the lead 
mining area in Western Ireland will be of great benefit and value in the 
planning of this pilot project for future European studies. 
Past experience of blood analyses to determine lead content has 
shown that there is room for considerable improvement in Community 
countries. The application of the directive requires that all blood 
lead measurements should give comparable results. During the seminar, 
therefore, a comparative programme on such measurements will be initiated 
and will take account of the sampling problems. 
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